Latest Breaking News On - Investors documentation - Page 1 : vimarsana.com

CARMAT: Availability of the 2023 Universal Registration Document

CARMAT: Availability of the 2023 Universal Registration Document
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

France generalBois darcyUnited statesExperte carsten storkDusan oresanskyZwei rohstoff chancenCaroline carmagnolFood drug administrationFrench financial markets authority autoritEuropean unionRegulatory newsDes marchInvestors documentationFrench medtechEarly feasibility studyEuronext growth

Forsee Power Announces the Availability of Its 2023 Universal Registration Document

Forsee Power Announces the Availability of Its 2023 Universal Registration Document
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesFrance generalSophie tricaudThomas grojeanNicolas merigeauCompany parisRegulatory newsRegistration documentForsee powerInvestors documentationUniversal registration documentEuropean single electronic formatNorth americaCarsten stork

Aelis Farma: Availability of the 2023 Universal Registration Document

Aelis Farma: Availability of the 2023 Universal Registration Document
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesVincenzo piazzaNeurocentre magendieDaelis farmaDennis riedlArthur rouillFrench financial markets authority autoritCorporate developmentRegulatory newsRegistration documentFrench financial markets authorityDes marchUniversal registration documentInvestors documentationGeneral meetingYear results

Aelis Farma: Publication of the 2022 Universal Registration Document

Regulatory News: Aelis Farma (ISIN: FR0014007ZB4 Ticker: AELIS) (Paris: AELIS), a clinical-stage biopharmaceutical company specialized in the development of treatments for brain diseases, announces

France generalUnited statesDaelis farmaArthur rouillVincenzo piazzaMagendie neurocenterFrench financial markets authority autoritRegulatory newsRegistration documentFrench financial markets authorityDes marchUniversal registration documentInvestors documentationGeneral meetingSignaling specificPier vincenzo piazza